Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "quest diagnostics"

FDA Clears The Focus Diagnostics Simplexa Flu A/B & RSV Direct Test To Include Eight Circulating Influenza Viruses
Medical Design Online

FDA Clears the Focus Diagnostics SimplexaT Flu A/B & RSV Direc...

As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics, announced that its Simplexa Flu A/B & RSV Direct Kit has received FDA clearance for eight additional influenza strains. These strains may pose ... Advance for Administrators of the Laboratory, 16 hours ago
[x]  

46 images for quest diagnostics

American Banking News, 18 hours ago
CEOWorld Magazine, 1 week ago
Yahoo! Finance, 2 weeks ago
Newsday, 1 week ago
Newsday, 1 week ago
Bio Spectrum Asia, 1 month ago
KXXV-TV, 2 weeks ago
I Stock Analyst, 2 weeks ago
PR Newswire, 2 weeks ago
Newsday, 3 weeks ago
American Banking News

Quest Diagnostics Sets New 52-Week High at $66.22 (DGX)

Shares of Quest Diagnostics (NYSE:DGX) hit a new 52-week high on Friday , Analyst Ratings Net reports. The stock traded as high as $66.22 and last traded at $66.04, with a volume of 678,455 shares. The stock had previously closed at $65.56. Several ...
 American Banking News3 hours ago Quest Diagnostics Rating Reiterated by Goldman Sachs (NYSE:DGX)  American Banking News18 hours ago Morningstar Gives BBB+ Credit Rating to Quest Diagnostics (DGX)  WKRB News2 days ago Quest Diagnostics Receives Consensus Rating of Hold from Analysts (NYSE:DGX)  Ticker Report1 week ago

Quest Diagnostics (DGX) Crosses Pivot Point Resistance at $64.20

Quest Diagnostics (NYSE:DGX) has opened bullishly above the pivot of $63.48 today and has reached the first level of resistance at $64.20. Analysts will be watching for a cross of the next upside pivot targets of $64.61
 Individual.com1 day ago Quest Diagnostics (DGX) Approaches New Upside Target of $65.05  Individual.com1 week ago

QUEST DIAGNOSTICS : RedHill boosted by University of Minnesota deal

Dec. 18 -- RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has entered into a license agreement with the University of Minnesota to acquire the rights to a patented technology to support the development of a commercial diagnostic test for ...
 4 Traders1 day ago RedHill Biopharma Acquires Technology from University of Minnesota as Part of Ongoing RHB-104 Phase III Crohn's Program  Stockwatch1 day ago RedHill boosted by University of Minnesota deal  Globes1 day ago RedHill Biopharma announces license agreement with University of Minnesota  Individual.com1 day ago
[x]  

Potential Quest Diagnostics (DGX) Trade Has 2.85% Downside Protection

The option-trade picking algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center have selected a covered-call trade on Quest Diagnostics Inc (http://www.marketintelligencecenter.com/symbol/DGX"DGX) that includes 2.85% downside ...
 Individual.com3 days ago Quest Diagnostics (DGX) Trading Near $64.05 Support Level  Individual.com1 week ago Quest Diagnostics (DGX) Showing Bullish Technicals With Support At $63.95  Individual.com1 week ago

2 Large Blood Testing Companies Stand To Be Disrupted

Summary A new blood testing technology is going to bring pain for Quest Diagnostics and Laboratory Corporation of America. Ordinarily, the chance of a new technology would just be enough to bring a risk to the companies exposed. Here, however, the ...
 Seeking Alpha3 days ago

Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again

New Jersey-based diagnostic testing, information and services provider Quest Diagnostics Inc .'s ( DGX ) Simplexa Flu A/B & RSV Direct Kit recently won the U.S. Food & Drug Administration (:FDA) clearance for testing eight additional influenza ...
 Yahoo! Finance1 week ago

Quest Diagnostics Test Kit Receives FDA Clearance For 8 More Virus Strains

Quest Diagnostics' (DGX: Quote) test kit has been cleared by the Food and Drug Administration for eight more influenza strains, the company said in a news release Tuesday. The company's Simplexa flu test was cleared by the FDA in 2012 for detecting ...
 RTTNews.com1 week ago QUIDEL : Gets FDA Clearance for AmpliVue Bordetella Assay  4 Traders2 days ago
Reuters

Quest Diagnostics : Reports Quarterly Cash Dividend

Quest Diagnostics reported that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on January 28, 2015 to shareholders of record of Quest Diagnostics common stock on January 13, 2015 . Quest Diagnostics is a ...
 4 Traders1 week ago Quest Diagnostics Declares Quarterly Cash Dividend  Financial Content2 weeks ago Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference  ADVFN UK2 weeks ago Quest Diagnostics : To Speak At The Piper Jaffray 26th Annual Healthcare Conference  4 Traders2 weeks ago
[x]  

Pacific Biosciences Appoints Kathy Ordonez to Board of Directors

Industry Veteran Previously Served as SVP at Quest Diagnostics and CEO of Celera and of Roche Molecular Systems MENLO PARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio(R) ...
 BizWire Express1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less